Next Article in Journal
Metabolic Variation among Fruits of Different Chili Cultivars (Capsicum spp.) Using HPLC/MS
Previous Article in Journal
Hop Leaves as an Alternative Source of Health-Active Compounds: Effect of Genotype and Drying Conditions
Previous Article in Special Issue
Phytochemical Characterization and Evaluation of the Antioxidant and Anti-Enzymatic Activity of Five Common Spices: Focus on Their Essential Oils and Spent Material Extractives
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Plants
Volume 11
Issue 1
10.3390/plants11010100
plants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Profiling of Polyphenolic Compounds of Leontopodium alpinum Cass Callus Cultures Using UPLC/IM-HRMS and Screening of In Vitro Effects

by
Ioana-Ecaterina Pralea
1,†,
Radu-Cristian Moldovan
1,†,
Adrian-Bogdan Țigu
2,
Alina-Maria Petrache
1,
Simona-Codruța Hegheș
3,
Monica Mitoi
4,
Gina Cogălniceanu
4 and
Cristina-Adela Iuga
1,3,*
1
Research Center for Advanced Medicine—MedFUTURE, Department of Proteomics and Metabolomics, “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, Louis Pasteur Street 6, 400349 Cluj-Napoca, Romania
2
Research Center for Advanced Medicine—MedFUTURE, Department of Translational Medicine, “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, Louis Pasteur Street 6, 400349 Cluj-Napoca, Romania
3
Department of Pharmaceutical Analysis, Faculty of Pharmacy, Iuliu Hațieganu University of Medicine and Pharmacy, Louis Pasteur Street 6, 400349 Cluj-Napoca, Romania
4
Department of Plant and Animal Cytobiology, Institute of Biology Bucharest, 296 Splaiul Independenței, 060031 Bucharest, Romania
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Plants 2022, 11(1), 100; https://doi.org/10.3390/plants11010100
Submission received: 14 December 2021 / Revised: 23 December 2021 / Accepted: 27 December 2021 / Published: 29 December 2021
(This article belongs to the Special Issue Antioxidant Activity of Medical Plants)
Browse Figures
Versions Notes

Abstract

:
Leontopodium alpinum Cass. (edelweiss) is recognized as a frequent constituent of anti-aging skin care products, providing increased antioxidant and anti-inflammatory defense. Considering the growing demand and the protected status of edelweiss in many countries, alternative methods of production have been developed, one of them being callus culturing. This study reports the phytochemical composition of a methanolic extract of L. alpinum callus cultures, characterized by liquid chromatography coupled to ion-mobility high resolution mass spectrometry (UPLC/IM-HRMS). The methanolic extract exhibited strong free radical scavenging activity (122.19 ± 7.28 mg AAE/g dw), while the quantitative evaluation revealed that four major constituents (phenylpropanoid derivatives) represent 57.13% (m/m) of the extract. Consequently, a screening of antiproliferative effects was performed on ten cancer cell lines, representative of prostate, colon, lung and breast cancer, showing inhibition of colony formation in all cases. These results provide a comprehensive phytochemical characterization of L. alpinum callus cultures using advanced IM-HRMS, while the in vitro explorations confirmed the potent antioxidant properties of edelweiss which are worth exploring further in cancer prevention.

1. Introduction

Leontopodium alpinum Cass. (edelweiss) is one of the most well-known members of the Asteraceae family. It grows on limestone surfaces, prefers the alpine climate and it is a protected species in many countries. In traditional medicine, edelweiss was used as remedy in digestive and respiratory illnesses as powder, infusion and tincture [1] or in the treatment of breast cancer, applied as a compress [2]. Nowadays, edelweiss is largely used in the cosmetic industry, especially in anti-aging products, for its remarkable antioxidant activity. Considering its protected status and the increased amount required by the industry, alternative technologies have been implemented in order to meet the demand, such as crop cultivation or cell tissue culturing techniques.
Callus culture (of non-differentiated, proliferating and metabolic active cells) is a developing technique for the production of useful compounds, including pharmaceuticals [3]. The most important advantages of in vitro plant cultures are represented by controlled growth environment and nutritive medium, season-independent metabolites production, selection of high-performance cell lines with specific, consistent levels of medicinal compounds, the absence of contaminants, and the possibility of maintaining cells indefinitely by regularly passaging [4]. Small-scale (glass flask) to large-scale (bioreactor) cell cultures have been successfully used for the production of medicinal metabolites [5].
Previous investigations [6,7,8,9,10,11,12] of Leontopodium alpinum phytochemical composition highlighted a number of compound classes, such as phenylpropanoid, sesquiterpene, benzofuran and lignan derivatives. However, data regarding the composition of callus cultures is rather limited [13,14]. So far, only the most abundant compounds have been identified, namely derivatives of quinic acid (chlorogenic acid and di-caffeoylquinic acid) and derivatives of glucaric acid (leontopodic acids A and B). The two leontopodic acids are specific to edelweiss and structurally are derivatives of glucaric acid substituted with caffeoyl and 3-hydroxybutanyl moieties [6], showing strong antioxidant potential.
During the last decade, the preclinical research on L. alpinum extracts effects has been focused on anti-inflammatory effect evaluation [14], leukotriene biosynthesis inhibition [15], anti-aging effects [16] and memory improving effects [17]. However, no research of edelweiss’s potential in chemoprevention has been published so far. Considering the successful valorization of the antioxidant properties in anti-aging formulations, it is of interest to assess the potential of edelweiss callus cultures in cancer management. Even though until today clinical trials have not demonstrated that dietary antioxidant supplements are beneficial in primary cancer prevention, plants are sources of potential active agents and lead molecules [18], due to the structural diversity of plant secondary metabolites (classes such as flavonoids, terpenes, alkaloids saponins, lignans and other molecules).
The aim of this study was to perform a comprehensive phytochemical characterization of edelweiss callus cultures. Following the assessment of the antioxidant capacity evaluation, two major cancer hallmarks were also investigated (proliferation and resisting cell death) using a panel of ten cancer cell lines representative of breast, prostate, lung and colon cancers.

2. Results

2.1. Extract Preparation and LC/IM-HRMS Phytochemical Characterization

The L. alpinum extract was obtained by microwave assisted extraction (MAE). In comparison to ultrasound assisted extraction (UAE), this technique was found to offer similar yield in a much shorter time (5 min for MAE compared to 45 min by UAE). The total extraction yield was calculated to be 26.4% (i.e., 264 mg of dry extract obtained from 1000 mg of dry frozen callus culture).
Further, the methanolic extract of edelweiss callus cultures was subjected to phytochemical profiling using a reversed phase LC/IM-HRMS method, achieving a good separation of the detected compounds (Figure 1). Considering the structures of the targeted analytes, the detection was performed using negative electrospray ionization followed by ion-mobility mass spectrometry.
Both targeted and untargeted strategies have been implemented to identify most of the compounds present in the extract. The targeted approach was based on literature reports of major phytochemical constituents in L. alpinum, whereas for the untargeted approach, a diagnostic product ion (DPI) strategy was implemented [19]. Using this strategy two important classes of derivatives were targeted in L. alpinum extract: glucaric acid derivatives and quinic acid derivatives. Therefore, glucaric acid (m/z 191.0192), peaks 2 and 3 (C6H7O7, 0.3 mDa), and quinic acid (m/z 191.0556), peak 1 (C7H12O6, 0.6 mDa) were used as DPI (see Supplementary Materials, Figures S1 and S2). Peak 4 was identified as dihydroxybenzoic acid glucoside (C13H16O9, 0.6 mDa) based on the fragmentation pattern and previous reports [20]. Out of a total of 27 detected compounds, 17 were identified with at least level 3 confidence [21] and a mass error below 1.9 mDa. A summary of the identified compounds is presented in Table 1.

2.1.1. Glucaric Acid and Quinic Acid Derivatives

Glucaric acid derivatives are the most abundant class of secondary metabolites identified in L. alpinum callus cultures. These derivatives are formed by the esterification of D-glucaric acid hydroxyl groups with caffeoyl and 3-hydroxybutanyl moieties. In total, 11 glucaric derivatives have been identified. Among these, peak 17 leontopodic acid A (C37H34O19, 1.9 mDa) and peak 13 leontopodic acid B (C33H28O17, 0.2 mDa) were the most abundant and their identification was validated using standards. Isomers of both leontopodic A and B were detected as peak 18 and 15, respectively.
A series of di-caffeoyl glucaric (C24H22O14, 1.2 mDa) isomers were identified as peaks 6, 7 and 8, while peak 24 represents tetra-caffeoyl glucaric acid (C42H34O22, 0.7 mDa), a tetra-substituted derivative [22]. Considering the fragmentation pattern of peak 26, it is most likely to be a penta-substituted glucaric acid derivative (C41H40O21, 0.7 mDa), with two 3-hydroxybutanyl and three caffeoyl moieties.
For the identification of quinic acid derivatives, quinic acid (m/z 191.0556) was used as DPI. Peaks 5 and 14 were identified by comparison with standards and annotated as chlorogenic acid (C16H18O9, 1.3 mDa) and 3,5-dicaffeoyl quinic acid (C25H24O12, 0.2 mDa), respectively. Two other di-caffeoyl quinic isomers (probably 3,4-dicaffeoyl quinic acid and 1,5-dicaffeoylquinic acid) were identified as peaks 12 and 16.

2.1.2. Quantitative Determinations

LC-MS quantitative determination was made for 4 of the top 5 most abundant identified compounds, i.e., leontopodic acids A and B, chlorogenic acid and 3-5-dicaffeoylquinic acid (Table 2).
The total polyphenol determination revealed that the L. alpinum extract contains 230.93 ± 6.6 (mg GAE/g dw), while the in vitro antioxidant activity of the extracts expressed in ascorbic acid equivalent antioxidant capacity (AEAC) was 122.19 ± 7.28 mg AAE/g dw, as determined using the 2,2-Diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay.

2.2. In Vitro Testing of the L. alpinum Extract

The phytochemical characterization of the LA extract highlighted high concentrations of polyphenolic derivatives with strong antioxidant activities. Consequently, we exposed a panel of diverse cancer cell lines (breast, colon, lung, and prostate cancers) to LA extract and performed several in vitro screenings. Particularly, we focused of two hallmarks of cancer, namely sustaining proliferative signaling (cellular proliferation and colony formation capabilities) and resisting cell death (morphological changes).

2.2.1. Viability Evaluation by MTT Assay

Effect of L. alpinum extract on cancer cell panel viability was studied by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The assay involves conversion of 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide by NADPH-dependent oxidoreductases to a purple-colored formazan product whose VIS absorbance is proportional to the number of metabolic active cells. Cells were grown in 96-well plates and treated with complete medium containing serial dilutions of extract (6.25–400 µg/mL). A blank control (complete medium only) and a positive control (100% DMSO) were included in every plate. The extract showed significant effect on cell viability at the highest tested concentration (400 µg/mL) on most cell lines (Figure 2), excepting estrogen positive MCF-7 breast cancer line and both androgen receptor positive LNCAP and 22RV1 prostate cancer cell lines. SK-MES-1 lung cancer representative and TNBC MDA-MB-231 cell lines had their viability diminished less than 50% by the LA extract while relative viability of H1792 lung cancer and TNBC HS578T cell lines was 66.2 ± 13.8% and 58.1 ± 13.4%, respectively. Similarly, the percentage of viable colon cancer cells HCT116 and DLD-1 after 48 h of treatment with 400 µg/mL L. alpinum extract decreased to 54.5 ± 14.8% and 71.1 ± 9.2%, correspondingly. Furthermore, 400 µg/mL of LA extract reduced viability in the non-cancer human fibroblast cell line BJ to 77.0 ± 9.7%. In addition, some of the cell lines had a significantly impaired viability compared to control at lower doses of LA extract (200 µg/mL): this is the case for SK-MES-1 (67.2 ± 23.8%) lung cancer cell line and MDA-MB-231 (77.21 ± 4.9%) and HS578T (67.4 ± 13.3%) TNBC representatives.
The 400 µg/mL dose of L. alpinum extract had the greatest impact on cell viability and was used in the in vitro functional assays conducted further.

2.2.2. Nucleus and the Cytoskeleton Morphological Analysis

The effect of the L. alpinum callus cultures’ methanolic extract on cellular morphology and cell distribution was evaluated by 4′,6-diamidino-2-phenylindole (DAPI) and Fluorescein phalloidin (Phalloidin-FITC) staining, used for nuclei and actin filaments labeling. The levels of toxicity and the antiproliferative effects were assessed by comparing control and treated cells groups. A summary of observed effects is found in Table 3, while the microscopy images are available in Supplementary Materials, Figure S3.
A substantial reduction of cell population was seen in the human non-cancer fibroblast (BJ cell line) and MDA-MB-231 TNBC in accordance with the viability assay conducted. Reduction of cell population was also observed in the case of both HCT-116 and DLD-1 colon cell lines. Particular to BJ cell line was the absence of signs of nuclear and cytoskeletal damage.
The L. alpinum extract induced nuclear fragmentation on most cell lines, excepting BJ, HS578T and SK-MES-1. Furthermore, multilobed nuclei were observed for HS578T, SK-MES-1, 22RV1, and HCT116, associated with rounding of cells. This last phenomenon was found also for H1792 and LNCAP in a less extensive manner. A marked cytoskeleton fragmentation was observed in the case of prostate cancer compared to the other cell lines.
Compared to TNBC cell lines, MCF-7 was less sensitive to L. alpinum extract, few cells presenting nuclear fragmentation and cytoskeleton damage, with most of the cells having similar shape to the control.

2.2.3. Clonogenic Cell Survival Assay

Another cancer feature is the capacity to develop secondary cancer sites, also known as metastatic sites. Colony assay was chosen to analyze this ability in vitro, by measuring the colony diameter of both control and treated cells (Figure 2 and microscopy captures in Supplementary Materials, Figure S4).
After treatment, 22RV1 and LNCAP prostate cells colonies were considerably reduced and both cell lines exhibited a low ability to create new colonies (Figure 3). Compared to the other cancer cell lines, exposing these cells to L. alpinum extract generated small and hardly visible colonies in the captures, the colony formation capacity of 22RV1 being half of control, while for LNCAP cells the capacity was even lower.
HCT116 colon cancer cells showed higher capacity to form colonies compared to DLD-1. The extract considerably inhibited the colony formation of both cell lines, with a pronounced effect on HCT116. Lung cancer cell lines (H1792 and SK-MES-1) showed high colony formation capacity, but the treatment reduced the colony number and size. The inhibitory effect of the treatment was confirmed on all three cell lines, the colony diameter being decreased by more than half compared to that of control. Similar to lung, colon and prostate cell lines, the extract inhibited colony formation was seen in all breast cancer cell lines. Breast cancer cell lines exhibited different colony formation capacities, the most potent being MCF-7, followed by MDA-MB-468 and the other two TNBC cell lines.

3. Discussion

In traditional medicine, L. alpinum was used mostly for its anti-inflammatory properties. Today, its current use is limited due to the protected species status that the plant has in many countries. However, the growing demand coming from the cosmetic industry, due to the antioxidant properties of L. alpinum, required the development of alternative means to obtain the specific constituents, such as callus cultures of edelweiss, now a world-wide substitute.
In medicine, many plant antioxidants have been shown to possess antitumoral properties [23]. Although edelweiss has been known to possess strong antioxidant properties, to our best knowledge no study has aimed to investigate/harness these properties in cancer research.
Microwave assisted extraction (MAE) and ultrasound assisted extraction (UAE) were assessed for the targeted extraction of polyphenolic compounds from edelweiss callus cultures, using the same extraction solvent (70% methanol). MAE was found to offer a faster extraction time (5 min), compared to UAE (45 min), both having comparable yield (data not shown). The dried extract was easily soluble in aqueous solutions, even at high concentrations (4 mg/mL stock solutions).
The polyphenol profiling of the L. alpinum extract was performed using LC/IM-HRMS. Compared to conventional mass spectrometry, ion-mobility mass spectrometry offers a supplementary separation dimension. Being a gas phase separation technique, ions are resolved based on their size and shape, depending on their collisional cross section (CCS). Ion-mobility mass spectrometry proved to be useful for differentiating between isomeric species [24]. Still, for the analysis of L. alpinum extract, no co-eluting isomeric species could be identified, all of them being resolved chromatographically before detection. The CCS values of the molecular ions of the constituents detected in the extract are presented in Table 1. As expected, small CCS differences were observed for the di-caffeoyl-glucaric acid isomers (peaks 6, 7 and 8) and di-caffeoyl quinic acid isomers (peaks 12, 14, 16). However, their separation by ion-mobility alone would probably not be possible considering the low resolution of today’s commercially available technology.
The analysis of the extract revealed 27 major constituents. The two detected classes of polyphenols were derivatives of glucaric and quinic acids, the most abundant being leontopodic acids A and B, chlorogenic acid and 3,5-dicaffeoyl quinic acid. Besides these already known constituents, several other derivatives were observed (some of which are reported for the first time in L. alpinum) such as isomers of leontopodic acids A and B, disubstituted derivatives of both glucaric (di-caffeoyl glucaric acids) and quinic acids (di-caffeoyl quinic acids), together with two highly substituted derivatives of glucaric acids (tetra-caffeoyl glucaric acid and a penta-substituted glucaric acid derivative).
Even though most of the detected compounds could be identified with a high degree of certitude, ten compounds remain unidentified. Most of these do not possess any similarity (molecular ion or fragment ions) with other compounds reported in the composition of L. alpinum, such as terpenes [9,10,11], lignans [25], or flavonoids [7].
Quantitative analysis of the most abundant four phenylpropanoid derivatives specific to L. alpinum (i.e., chlorogenic acid, 3,5-dicaffeoyl quinic acid, leontopodic acids A and B) (Table 2) revealed that they represent more than 57% (m/m) of the dry-frozen extract and around 15% (m/m) of the dry-frozen callus culture. The measured concentrations of these four constituents in callus culture extracts are comparable or higher than in wild plant [16] and confirm the high quantity of polyphenols obtained by the total polyphenol content determination. Therefore, they are expected to be responsible for the effects observed in the in vitro assays that were carried out. The extract also showed strong antioxidant activity as determined through the DPPH free radical scavenging assay, in agreement with previous studies [13,16].
Considering the high quantity of polyphenols determined in the edelweiss callus cultures, an in vitro screening procedure was implemented which allowed the evaluation of the extract on three cancer hallmarks. Its effects were studied on ten cancer cell lines, representative of four different cancer types. A summary of the obtained results is presented in Table 3.
The cytotoxic effect of L. alpinum callus cultures extract was evaluated in vitro using the MTT assay. Decreased cell viability was observed at the highest concentration tested (400 µg/mL) for TNBC breast cell lines MDA-MB-231 and HS578T, both colon (DLD-1, HCT-116), and in lung cancer cell lines (SK-MES-1 and H1792). In the specific case of MCF-7, an estrogen dependent cell line, pro-proliferative effects have been observed. It has already been documented that polyphenols, due to their chemical structure, can interact with estrogen receptors with different affinity towards estrogen receptors α and β. A deeper insight into the mechanisms involving polyphenols’ effects on hormone dependent cancer cell lines can be found in a comprehensive review published by Cipolletti et al. [26].
Next, other cancer hallmarks were studied in order to observe potential induced morphological changes and colony formation capabilities. Colony formation was inhibited for all cell lines, presenting substantially reduced diameters (Figure 2), with pronounced inhibition being observed on HCT116, H1792 and MDA-MB-231 cell lines, both assays being in accordance with the morphological analysis (see Supplementary Materials, Figure S3). The extract induced morphological alterations, major differences being observed between control and treated groups on several cell lines: an augmented nuclear fragmentation was observed in 22RV1 and HCT116, while the prostate cancer cells presented a distorted cytoskeleton. Rounding of cells was observed in HS578T, SK-MES-1 and less extensively in H1792 and HCT-116. On the other hand, MDA-MB-468 and MCF-7 cell lines were less affected by the treatment, cell populations not being considerably reduced, with fewer nuclear fragmentations. Membrane blebbing was be observed on MDA-MB-468 as a sign of cellular stress, but without effect on cell population.
These results could be attributed to the high quantity of polyphenols which are known to modulate pathways relevant to proliferation, migration or colony formation and in some particular cases cell death could be triggered [27,28,29,30].
Using in vitro models, polyphenols were previously described to possess anticarcinogenic properties, capable of inhibiting tumor growth, metastasis and inflammatory processes [31,32,33]. The major constituents of the edelweiss callus culture extract have been previously reported to possess strong antioxidant properties, protecting cells against DNA damage [6]. For example, chlorogenic acid, one of the major constituents of the extract, can affect GSK-3β, APC and β-catenin gene expression acting as an antitumor agent [34]. It was also described that it is able to interact with key molecules that can further modulate critical biological pathways involved in cell survival or proliferation [34]. It was also shown that chlorogenic acid can enhance the antitumor effect of conventional therapeutic agents like doxorubicin by protecting the non-cancer cells against doxorubicin toxicity [35] or induce hypomethylation of Jurkat cells, being benefic in the case of hematological malignancies [27].
The second quinic acid derivative found in high quantities in L. alpinum extract, 3-5-dicaffeoylquinic acid, acts as antioxidant agent with neuroprotective effects [36]. On top, 3,5-dicaffeoylquinic acid was shown to protect cardiomyocytes cell line from apoptosis by increasing activation of the PI3K/Akt signaling pathway [37]. The antiproliferative effect of several di-caffeoylquinic acids including 3,5-dicaffeoylquinic acid was demonstrated on MCF-7 and MDA-MB-231 breast cancer cells with reported IC50 below 300 µM (MTT assay, 48 h treatment) [38]. The authors reported 1,3-dicaffeoylquinic acid as potent inhibitor of 14-3-3τ protein, thus preventing breast cancer proliferation and metastasis via Jak/PI3K/Akt and Raf/ERK pathway.
Unfortunately, less is known about the potential anticancer mechanisms of actions of the leontopodic acids A and B, the other two major constituents of L.alpinum callus cultures, and remains a subject open to research.

4. Materials and Methods

4.1. Chemicals and Reagents

The reference standards of chlorogenic acid, 3,5-dicaffeoylquinic acid and leontopodic acids A and B which were used in this work were acquired from Extrasynthese (Genay, France). The organic solvents, methanol and acetonitrile, used for mobile phases and extractions were of LC-MS purity and were purchased from Merck (Darmstadt, Germany). Ultrapure water was produced with a Purelab water filtration system (Elga LabWater, Celle, Germany), while MS grade formic acid was produced by Carlo Erba (Val de Reuil, France). 2,2-Diphenyl-1-picrylhydrazyl and Folin-Ciocâlteu’s phenol reagent were purchased from Sigma (Steinheim, Germany), ascorbic acid was produced by International Laboratory (Cluj-Napoca, Romania), and sodium carbonate by Lachner (Neratovice, Czechia).

4.2. Biological Material

Commercial seeds of Leontopodium alpinum Cass. (www.semintelegumeflori.ro (accessed on 10 December 2021), batch Pl730/12/210/1274A, SC XTREME ANG MARKETING SRL, Bucharest, Romania), aseptically germinated, and seedlings were used to initiate the callus culture on Gamborg medium [39], supplemented with 2,4-dichlorophenoxyacetic acid, 6-benzylaminopurine, indole-3-acetic acid, sucrose, casein hydrolisate, calcium carbonate and agar. The cultures were grown in a Fitotron Weiss-Gallenkamp SCG 120 (Weiss Technik, Loughborough, UK) with a photoperiod of 16 h light/8 h dark, at a temperature of 25 °C and sub-cultivated on the same fresh medium every 3 weeks. (Patent pending).

4.3. Extract Preparation

Prior to extraction, L. alpinum callus cultures from three batches were freeze-dried (0.5 mbar, −55 °C) using a LyoQuest -55 Plus instrument (Telstar, Terrassa, Spain), then all samples were mixed to create a representative sample which was further used for this study. Ultrasound assisted extraction (UAE) and microwave assisted extraction (MAE) were assessed in order to find the most suitable extraction conditions.
For UAE, 20 mg of freeze-dried sample was suspended in 1 mL of 70% methanol (v/v), then sonicated for 45 min at 37 kHz (Elmasonic S 30H, Elma, Singen, Germany) [19]. MAE (by means of Multiwave PRO (Anton Paar, Graz, Austria)) was performed starting from 120 mg of freeze-dried sample which was placed into the extraction vessel and suspended in 6 mL of 70% methanol (v/v) [40]. The experiment was carried at 60 °C for 5 min, the microwave power varying up to 500 W [41,42,43]. Then, the extracts obtained by both UAE and MAE were centrifuged for 10 min at 8000 rpm and liquid-liquid extraction with n-hexane 1:1 (v/v) was performed 3 times (for removal of lipid components), the organic phase being discarded [44]. The methanol phase was evaporated using a rotary evaporator (40 °C, 150 mbar) (Heidolph Instruments, Schwabach, Germany), then the remaining aqueous phase was freeze-dried (0.5 mbar, −55 °C).

4.4. Chromatographic Method and Instrumentation

All analyses performed for the phytochemical characterization were carried out on a Waters I-Class UPLC instrument coupled with a Synapt G2-Si high resolution mass spectrometer (Waters, Milford, MA, USA). The separations were achieved by reversed phase using a BEH C18 (100 × 2.1 mm) stationary phase (Waters, Milford, MA, USA) and mobile phases formed of 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B), being pumped at a flow rate of 0.3 mL/min at a temperature of 45 °C. Gradient elution was implemented as follows: 0 min 3%B–10 min 40%B–15 min 98%B. The mass spectrometer was set in resolution mode using negative electrospray ionization (2 kV capillary voltage), with source temperature of 130 °C. Data independent acquisition was achieved in two modes: (i) HDMSE (ion-mobility enabled) for qualitative runs and identification purposes and (ii) MSE (Q-ToF only) for quantification. Data was acquired in the range of 50 to 1200 m/z, using 2 functions. The collision energies were set to 4 eV (trap) and 2 eV (transfer) for the first function and a ramp between 20–45 eV (trap) for the second function. Leucine-encephalin was used as single point reference (m/z 554.2615).
Data processing (peak picking, alignment) was carried out using Progenesis QI software version 3.0.76 (Waters, Milford, MA, USA). A first identification was performed on the most abundant compounds by using an in-house natural compounds library. Major compounds were putatively annotated based on their accurate mass, fragmentation pattern, available reference standards and on other previous studies.
Quantitative determinations of leontopodic acids A and B, chlorogenic acid and 3-5-dicaffeoylquinic acid were made by constructing a 5-point calibration curve (0.1–40 µg/mL) for each analyte. Each standard solution was injected 2 times and the quantitative analysis was performed using the TargetLynx module of MassLynx software (Waters, Milford, MA, USA), by measuring the molecular peak areas of the analytes. Injection repeatability was assessed by injecting 5 times the previously mentioned standards (RSD less than 3.85%). Two replicates of the extract were prepared, then analyzed twice, after a 40-fold dilution.

4.5. Antioxidant Activity through DPPH Free Radical Scavenging Assay

Antioxidant assay was performed using a microplate protocol described by Navarro et al. [45]. Two series of dilutions of extract (1.56–500 µg/mL) and ascorbic acid (0.19–50 µg/mL) were prepared. 20 μL of sample was added to 180 μL of DPPH solution (150 μM) in methanol–water (80:20, v/v) and shaken for 60 s. The mixtures were kept for 40 min in darkness at room temperature, then absorbance at λ = 515 nm was measured using a Clariostar Plus microplate reader (BMG Labtech, Ortenberg, Germany). The blank sample consisted of 20 μL of water with 180 μL of methanol:water (80:20, v/v), while the control sample was 20 μL of water with 180 μL of DPPH solution. Each determination was performed in triplicate and the percentage of quenched DPPH was determined using Equation (1).
% D P P H   q u e n c h e d = [ 1 − ( A s a m p l e − A b l a n k A c o n t r o l − A b l a n k ) ]   ×   100
By calculating the concentrations of sample and extracts equivalent to 50% quenched DPPH, the ascorbic acid equivalent antioxidant capacity was determined.

4.6. Total Polyphenols Content Determination

The total polyphenols determination was made according to the method described by Singleton et al. [46] and modified by Mihailovic et al. [47], adapted to microplate determinations. In brief, 100 µL of Folin-Ciocâlteu reagent (diluted 4-fold) was added to 20 µL of extract solution or gallic acid standards (10–200 µg/mL). After 3 min, 75 µL of Na2CO3 was added, followed by incubation at room temperature and darkness for 2 h. The solution absorbance was measured at λ = 765 nm (Clariostar Plus, BMG Labtech, Ortenberg, Germany). The determination was made in triplicate. The gallic acid calibration curve was built, showing a linear range for concentrations between 10–200 μg/mL gallic acid. The total polyphenol content of extracts was expressed as mg of gallic acid equivalents (GAE)/g dry weight (dw), using the Equation (2) based on the calibration curve [48].
T = C   ×   V M
where, T = the total phenolic content in mg/mL as GAE; C = the concentration of gallic acid from the calibration curve in mg/mL; V = the volume of the extract solution in mL; M = the weight of the extract in g.

4.7. Cell Cultures and Assays

A panel consisting of twelve human cell lines was chosen for the in vitro evaluation of L. alpinum extract. Non-cancer human epithelial fibroblast (BJ—ATCC CRL-2522) and double positive breast cancer cell line (MCF7—ATCC HTB-22) were cultivated in MEM supplemented with 10% Fetal Bovine Serum (FBS) and 1% Penicillin/Streptomycin. Triple negative breast cancer cell lines (MDA-MB-231—ATCC HBT-26, MDA-MB-468—ATCC HBT-132 and HS578T—ATCC HBT-126), lung cancer cell lines (H1792—ATCC CRL-5895 and SK-MES-1—ATCC HTB-58), colon cancer cell line DLD-1 (ATCC CCL-221) and prostate cancer cell lines (LNCAP—ATCC CRL-1740 and 22RV1 ATCC CRL-2505) were maintained in RPMI supplemented with 10% FBS, 1% Penicillin/Streptomycin and 1% Glutamine, while HCT116 colon cancer cell line (ATCC CCL-247) was cultivated in McCoy’s supplemented with 10% FBS and 1% Penicillin/Streptomycin. All cell lines were maintained in a humidified chamber, at 37 °C and 5% CO2. All the reagents needed for cell culturing were purchased from Gibco (Dublin, Ireland).
The L. alpinum extract stock solution was prepared at a concentration of 4 mg/mL by dissolving the necessary amount of freeze-dried extract in the appropriate culture medium for each cell line. Subsequent dilutions were prepared at specific concentrations needed for the different assays.

4.7.1. Cell Viability Testing by MTT Assay

The effect of L. alpinum callus cultures’ methanolic extract was investigated using the MTT assay. Cells were grown at a density of 1 × 104 cells/well in a 96-well flat-bottom plate, each treatment having 3 replicates. After 24 h incubation, cells were treated with different concentrations of extract (6.25–400 μg/mL) for 48 h. To remove possible extract residues that might interfere with MTT assay, a wash step with Phosphate Buffer Saline 1× (PBS) was performed, then cell viability was determined after incubation for 3 h with 100 μL 1 mg/mL MTT. Afterwards, the solution was removed and 150 μL of DMSO were added to dissolve the crystals. The absorbance corresponding to the viable cells was measured at λ = 570 nm on a SPARK10M multiplate reader (Tecan, Männedorf, Switzerland). A blank control (medium only), and a positive control (DMSO 100%), were included on every plate. The experiment was repeated three times. Statistical analysis was performed using Graphpad Prism (version 8) software (GraphPad Software, San Diego, CA, USA). Cell viabilities were expressed as percentage of control (set as 100%) and represented as mean ± SEM. Data was analyzed by one-way ANOVA followed by Dunnett’s multiple-comparison test.

4.7.2. Colony Forming Assay

An equal number of cells (500 cells/well) were seeded in a 6-well plate, both for control and treatment. After 24 h the cells were treated with L. alpinum extract (400 µg/mL) and incubated for 48 h, then the cell culture medium was replaced with treatment free medium. Cells were observed daily up to 14 days and when the colonies reached the proper size (more than 50 cells/colony) or when the colonies were too close to another, the experiment was stopped and the cells were fixed with methanol and stained with crystal violet (Sigma-Aldrich, St. Louis, MO, USA) [49,50]. The colonies were observed using a Zeiss Axio Vert A1 inverted microscope (Zeiss, Jena, Germany), colonies diameter being determined using ZEN software (Zeiss, Jena, Germany), by measuring the diameter of three random colonies. Statistical analysis was done on Graphpad Prism (version 8) software (GraphPad Software, San Diego, CA, USA). An unpaired t-test was applied to determine significant differences in colony numbers. *

4.7.3. Morphological Analysis

To investigate the morphological changes induced by the 48 h treatment with L. alpinum extract (400 µg/mL), cells were analyzed in bright field with an inverted microscope. The same instrument was used in combination with a fluorescent source (HBO50, same manufacturer) for details regarding the cytoskeleton and nucleus, after staining these cell compartments with Phalloidin-FITC (for the cytoskeleton) (Cytoskeleton, Denver, CO, USA) and DAPI (for the nucleus) (Thermo Fisher Scientific, Waltham, MS, USA) using a previously published protocol [50].

5. Conclusions

The phytochemical profiling of L. alpinum callus cultures revealed high quantities of polyphenols, most of them being derivatives of glucaric and quinic acids. The four most abundant represent more than 57% (m/m) of the dry-frozen extract and around 15% (m/m) of the dry-frozen callus culture, demonstrating that in vitro culturing can be a useful alternative to produce natural compounds.
The screening of cancer cell lines revealed that the L. alpinum callus cultures extract demonstrated interesting effects regarding its capacity to inhibit proliferation and colony formation. L. alpinum callus cultures extract showed considerable inhibitory effect on SK-MES-1, MDA-MB-231 and HCT116 cell lines, most probably being related to the high content in polyphenolic compounds which exhibit strong antioxidant capacity.
Considering its abilities to inhibit cancer proliferation and colony formation, the use of L. alpinum as chemosensitizer might represent a perspective. To better understand the possible effects of leontopodic acids A and B, further research could also focus on evaluating the proliferation, migration or colony formation assays on cancer cells treated with these two natural products.

6. Patents

Cogălniceanu G. C., Mitoi E. M., Ciocan A. G., Holobiuc M. I., Maximilian R. C., Helepciuc F. E., Morosanu A. M. Biotechnological procedure for initiating and obtaining high proliferative cell mass producing bioactive compounds in Leontopodium alpinum Cass. (Edelweiss) and the crude extract, OSIM Romania Patent Application A/00740/17.11.2020.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/plants11010100/s1, Figure S1. Diagnostic product ion—glucaric acid; Figure S2. Diagnostic product ion—quinic acid; Figure S3. Morphological analysis; Figure S4. Colony assay.

Author Contributions

Conceptualization, C.-A.I., I.-E.P. and R.-C.M.; methodology, R.-C.M., I.-E.P., A.-B.Ț., A.-M.P.; formal analysis, R.-C.M., I.-E.P., A.-B.Ț., A.-M.P.; S.-C.H.; writing—original draft preparation, R.-C.M., I.-E.P., A.-B.Ț.; writing—review and editing, M.M., G.C., C.-A.I.; supervision, project administration, C.-A.I. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by a grant of the Romanian Ministry of Research and Innovation, CCCDI- UEFISCDI, project number PN-III-P1-1.2-PCCDI-2017-0323/no.5/2018, within PNCDI III.

Data Availability Statement

All data used in and created by this study are included in this publication as tables, figures, and Supplementary Files.

Acknowledgments

The authors would like to thank Alina Uifălean from Department of Pharmaceutical Analysis, Faculty of Pharmacy, “Iuliu Hațieganu” University of Medicine and Pharmacy for proofreading the manuscript. This paper was published under the frame of European Social Found, Human Capital Operational Programme 2014–2020, project No. POCU/380/6/13/125171.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Dweck, A.C. A review of Edelweiss. Softw. J. 2004, 130, 65–67. [Google Scholar]
  2. Tauchen, J.; Kokoska, L. The chemistry and pharmacology of Edelweiss: A review. Phytochem. Rev. 2017, 16, 295–308. [Google Scholar] [CrossRef]
  3. Efferth, T. Biotechnology Applications of Plant Callus Cultures. Engineering 2019, 5, 50–59. [Google Scholar] [CrossRef]
  4. Jain, S.M.; Saxena, P.K. Protocols for In Vitro Cultures and Secondary Metabolite Analysis of Aromatic and Medicinal Plants; Methods in Molecular Biology; Humana Press: Totowa, NJ, USA, 2009; Volume 547, ISBN 9781603272865. [Google Scholar]
  5. Ramachandra Rao, S.; Ravishankar, G.A. Plant cell cultures: Chemical factories of secondary metabolites. Biotechnol. Adv. 2002, 20, 101–153. [Google Scholar] [CrossRef]
  6. Seger, C.; André, P.; Gafner, F.; Renimel, I.; Schwaiger, S.; About, N.; Stuppner, H.; Godenir, C.; Ellmerer, E.P.; Cervellati, R. Leontopodic acid—A novel highly substituted glucaric acid derivative from Edelweiss (Leontopodium alpinum Cass.) and its antioxidative and DNA protecting properties. Tetrahedron 2005, 61, 4621–4630. [Google Scholar]
  7. Schwaiger, S.; Seger, C.; Wiesbauer, B.; Schneider, P.; Ellmerer, E.P.; Sturm, S.; Stuppner, H. Development of an HPLC-PAD-MS assay for the identification and quantification of major phenolic edelweiss (Leontopodium alpium Cass.) constituents. Phytochem. Anal. 2006, 17, 291–298. [Google Scholar] [CrossRef]
  8. Ganzera, M.; Greifeneder, V.; Schwaiger, S.; Stuppner, H. Chemical profiling of Edelweiss (Leontopodium alpinum Cass.) extracts by micellar electrokinetic capillary chromatography. Fitoterapia 2012, 83, 1680–1686. [Google Scholar] [CrossRef] [PubMed]
  9. Dobner, M.J.; Ellmerer, E.P.; Schwaiger, S.; Batsugkh, O.; Narantuya, S.; Stütz, M.; Stuppner, H. New lignan, benzofuran, and sesquiterpene derivatives from the roots of Leontopodium alpinum and L. leontopodioides. Helv. Chim. Acta 2003, 86, 733–738. [Google Scholar] [CrossRef]
  10. Stuppner, H.; Ellmerer, E.P.; Ongania, K.H.; Dobner, M. Bisabolane derivatives from Leontopodium alpinum. Helv. Chim. Acta 2002, 85, 2982–2989. [Google Scholar] [CrossRef]
  11. Comey, N.; Grey, A.I.; Hook, I.L.; James, P.; Sheridan, H. Sesquiterpenes from Leontopodium alpinum. Phytochemistry 1999, 50, 1057–1060. [Google Scholar] [CrossRef]
  12. Marlot, L.; Batteau, M.; Escofet, M.C.; Nuccio, S.; Coquoin, V.; De Vaumas, R.; Faure, K. Two-dimensional multi-heart cutting centrifugal partition chromatography–liquid chromatography for the preparative isolation of antioxidants from Edelweiss plant. J. Chromatogr. A 2017, 1504, 55–63. [Google Scholar] [CrossRef]
  13. Mallón, R.; Corral, P.; Lota, F.; Onrubia, M.; Lorrain, B.; Michoux, F.; García-Medel, N.; Muñoz, E. Active Biotechnological Ingredients from Edelweiss: Evaluation of the impact of plant genotype on in vitro activities. In Proceedings of the 23 IFSCC Conference Zurich, Zurich, Switzerland, 21–23 September 2015; pp. 1–14. [Google Scholar]
  14. Lulli, D.; Potapovich, A.; Maurelli, R.; Dellambra, E.; Pressi, G.; Kostyuk, V.; Dal Toso, R.; De Luca, C.; Pastore, S.; Liudmila, K. Anti-inflammatory effects of concentrated ethanol extracts of Edelweiss (Leontopodium alpinum Cass.) callus cultures towards human keratinocytes and endothelial cells. Mediat. Inflamm. 2012, 2012, 1–12. [Google Scholar]
  15. Schwaiger, S.; Adams, M.; Seger, C.; Ellmerer, E.P.; Bauer, R.; Stuppner, H. New constituents of Leontopodium alpinum and their in vitro leukotriene biosynthesis inhibitory activity. Planta Med. 2004, 70, 978–985. [Google Scholar] [CrossRef] [PubMed]
  16. Cho, W.K.; Kim, H.I.; Kim, S.Y.; Seo, H.H.; Song, J.; Kim, J.; Shin, D.S.; Jo, Y.; Choi, H.; Lee, J.H.; et al. Anti-aging effects of Leontopodium alpinum (Edelweiss) callus culture extract through transcriptome profiling. Genes 2020, 11, 230. [Google Scholar] [CrossRef] [Green Version]
  17. Hornick, A.; Schwaiger, S.; Rollinger, J.M.; Vo, N.P.; Prast, H.; Stuppner, H. Extracts and constituents of Leontopodium alpinum enhance cholinergic transmission: Brain ACh increasing and memory improving properties. Biochem. Pharmacol. 2008, 76, 236–248. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Miller, J.S. The Discovery of Medicines from Plants: A Current Biological Perspective. Econ. Bot. 2011, 65, 396–407. [Google Scholar] [CrossRef]
  19. Garran, T.A.; Ji, R.; Chen, J.; Xie, D.; Guo, L.; Huang, L.; Lai, C. Elucidation of metabolite isomers of Leonurus japonicus and Leonurus cardiaca using discriminating metabolite isomerism strategy based on ultra-high performance liquid chromatography tandem quadrupole time-of-flight mass spectrometry. J. Chromatogr. A 2019, 1598, 141–153. [Google Scholar] [CrossRef]
  20. Gómez-Caravaca, A.M.; López-Cobo, A.; Verardo, V.; Segura-Carretero, A.; Fernández-Gutiérrez, A. HPLC-DAD-q-TOF-MS as a powerful platform for the determination of phenolic and other polar compounds in the edible part of mango and its by-products (peel, seed, and seed husk). Electrophoresis 2016, 37, 1072–1084. [Google Scholar] [CrossRef] [PubMed]
  21. Schrimpe-Rutledge, A.C.; Codreanu, S.G.; Sherrod, S.D.; McLean, J.A. Untargeted metabolomics strategies—Challenges and emerging directions. J. Am. Soc. Mass Spectrom. 2016, 27, 1897–1905. [Google Scholar] [CrossRef] [Green Version]
  22. Cicek, S.S.; Untersulzner, C.; Schwaiger, S.; Zidorn, C. Caffeoyl-D-glucaric acid derivatives in the genus Gnaphalium (Asteraceae: Gnaphalieae). Rec. Nat. Prod. 2012, 6, 311–315. [Google Scholar]
  23. Prasad, S.; Gupta, S.C.; Tyagi, A.K. Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals. Cancer Lett. 2017, 387, 95–105. [Google Scholar] [CrossRef]
  24. Wu, Q.; Wang, J.Y.; Han, D.Q.; Yao, Z.P. Recent advances in differentiation of isomers by ion mobility mass spectrometry. TrAC Trends Anal. Chem. 2020, 124, 115801. [Google Scholar] [CrossRef]
  25. Reisinger, U.; Schwaiger, S.; Zeller, I.; Messner, B.; Stigler, R.; Wiedemann, D.; Mayr, T.; Seger, C.; Schachner, T.; Dirsch, V.M.; et al. Leoligin, the major lignan from Edelweiss, inhibits intimal hyperplasia of venous bypass grafts. Cardiovasc. Res. 2009, 82, 542–549. [Google Scholar] [CrossRef]
  26. Cipolletti, M.; Fernandez, V.S.; Montalesi, E.; Marino, M.; Fiocchetti, M. Beyond the antioxidant activity of dietary polyphenols in cancer: The modulation of estrogen receptors (ERs) signaling. Int. J. Mol. Sci. 2018, 19, 2624. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Hernandes, L.C.; Machado, A.R.T.; Tuttis, K.; Ribeiro, D.L.; Aissa, A.F.; Dévoz, P.P.; Antunes, L.M.G. Caffeic acid and chlorogenic acid cytotoxicity, genotoxicity and impact on global DNA methylation in human leukemic cell lines. Genet. Mol. Biol. 2020, 43, 1–8. [Google Scholar] [CrossRef] [PubMed]
  28. Msuya, T.S.; Mndolwa, M.A. Catha edulis: A threatened tree in the West Usambara Mountains, Tanzania. J. Trop. For. Sci. 2005, 17, 526–531. [Google Scholar]
  29. Tsai, H.C.; Li, Y.C.; Hsu, S.H.; Young, T.H.; Chen, M.H. Inhibition of growth and migration of oral and cervical cancer cells by citrus polyphenol. J. Formos. Med. Assoc. 2016, 115, 171–185. [Google Scholar] [CrossRef] [Green Version]
  30. Sajadimajd, S.; Bahramsoltani, R.; Iranpanah, A.; Kumar Patra, J.; Das, G.; Gouda, S.; Rahimi, R.; Rezaeiamiri, E.; Cao, H.; Giampieri, F.; et al. Advances on Natural Polyphenols as Anticancer Agents for Skin Cancer. Pharmacol. Res. 2020, 151, 104584. [Google Scholar] [CrossRef] [PubMed]
  31. Fantini, M.; Benvenuto, M.; Masuelli, L.; Frajese, G.V.; Tresoldi, I.; Modesti, A.; Bei, R. In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: Perspectives on cancer treatment. Int. J. Mol. Sci. 2015, 16, 9236–9282. [Google Scholar] [CrossRef] [Green Version]
  32. Benvenuto, M.; Albonici, L.; Focaccetti, C.; Ciuffa, S.; Fazi, S.; Cifaldi, L.; Miele, M.T.; De Maio, F.; Tresoldi, I.; Manzari, V.; et al. Polyphenol-mediated autophagy in cancer: Evidence of in vitro and in vivo studies. Int. J. Mol. Sci. 2020, 21, 6635. [Google Scholar] [CrossRef]
  33. Niedzwiecki, A.; Roomi, M.W.; Kalinovsky, T.; Rath, M. Anticancer efficacy of polyphenols and their combinations. Nutrients 2016, 8, 552. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Xu, R.; Kang, Q.; Ren, J.; Li, Z.; Xu, X. Antitumor molecular mechanism of chlorogenic acid on inducting genes GSK-3 β and APC and inhibiting gene β -catenin. J. Anal. Methods Chem. 2013, 2013, 951319. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Abd Elrazik, N.A.; El-Mesery, M.; El-Karef, A.; Eissa, L.A.; El Gayar, A.M. Chlorogenic acid potentiates antitumor effect of doxorubicin through upregulation of death receptors in solid Ehrlich carcinoma model in mice. Egypt. J. Basic Appl. Sci. 2019, 6, 158–172. [Google Scholar] [CrossRef]
  36. Kim, S.S.; Park, R.Y.; Jeon, H.J.; Kwon, Y.S.; Chun, W. Neuroprotective effects of 3,5-dicaffeoylquinic acid on hydrogen peroxide-induced cell death in SH-SY5Y cells. Phyther. Res. 2005, 19, 243–245. [Google Scholar] [CrossRef] [PubMed]
  37. Bi, Y.M.; Wu, Y.T.; Chen, L.; Tan, Z.B.; Fan, H.J.; Xie, L.P.; Zhang, W.T.; Chen, H.M.; Li, J.; Liu, B.; et al. 3,5-dicaffeoylquinic acid protects H9C2 cells against oxidative stress-induced apoptosis via activation of the PI3K/Akt signaling pathway. Food Nutr. Res. 2018, 62, 1–8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Zhou, Y.; Fu, X.; Guan, Y.; Gong, M.; He, K.; Huang, B. 1,3-Dicaffeoylquinic acid targeting 14-3-3 tau suppresses human breast cancer cell proliferation and metastasis through IL6/JAK2/PI3K pathway. Biochem. Pharmacol. 2020, 172, 113752. [Google Scholar] [CrossRef]
  39. Gamborg, O.L.; Miller, R.A.; Ojima, K. Nutrient requirements of suspension cultures of soybean root cells. Exp. Cell Res. 1968, 50, 151–158. [Google Scholar] [CrossRef]
  40. Cheng, X.L.; Wan, J.Y.; Li, P.; Qi, L.W. Ultrasonic/microwave assisted extraction and diagnostic ion filtering strategy by liquid chromatography-quadrupole time-of-flight mass spectrometry for rapid characterization of flavonoids in Spatholobus suberectus. J. Chromatogr. A 2011, 1218, 5774–5786. [Google Scholar] [CrossRef]
  41. Hayat, K.; Zhang, X.; Farooq, U.; Abbas, S.; Xia, S.; Jia, C.; Zhong, F.; Zhang, J. Effect of microwave treatment on phenolic content and antioxidant activity of citrus mandarin pomace. Food Chem. 2010, 123, 423–429. [Google Scholar] [CrossRef]
  42. Li, Y.; Skouroumounis, G.K.; Elsey, G.M.; Taylor, D.K. Microwave-assistance provides very rapid and efficient extraction of grape seed polyphenols. Food Chem. 2011, 129, 570–576. [Google Scholar] [CrossRef]
  43. Jokić, S.; Cvjetko, M.; Božić, D.; Fabek, S.; Toth, N.; Vorkapić-Furač, J.; Redovniković, I.R. Optimisation of microwave-assisted extraction of phenolic compounds from broccoli and its antioxidant activity. Int. J. Food Sci. Technol. 2012, 47, 2613–2619. [Google Scholar] [CrossRef]
  44. Peričin, D.; Krimer, V.; Trivić, S.; Radulović, L. The distribution of phenolic acids in pumpkin’s hull-less seed, skin, oil cake meal, dehulled kernel and hull. Food Chem. 2009, 113, 450–456. [Google Scholar] [CrossRef]
  45. Bobo-García, G.; Davidov-Pardo, G.; Arroqui, C.; Vírseda, P.; Marín-Arroyo, M.R.; Navarro, M. Intra-laboratory validation of microplate methods for total phenolic content and antioxidant activity on polyphenolic extracts, and comparison with conventional spectrophotometric methods. J. Sci. Food Agric. 2015, 95, 204–209. [Google Scholar] [CrossRef] [PubMed]
  46. Singleton, V.L.; Orthofer, R.; Lamuela-Raventós, R.M. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzimol. 1999, 299, 152–178. [Google Scholar]
  47. Mihailović, V.; Matić, S.; Mišić, D.; Solujić, S.; Stanić, S.; Katanić, J.; Mladenović, M.; Stanković, N. Chemical composition, antioxidant and antigenotoxic activities of different fractions of gentiana asclepiadea l. Roots extract. EXCLI J. 2013, 12, 807–823. [Google Scholar]
  48. Abdelhady, M.I.S.; Motaal, A.A.; Beerhues, L. Total phenolic content and antioxidant activity of standardized extracts from leaves and cell cultures of three callistemon species. Am. J. Plant Sci. 2011, 2, 847–850. [Google Scholar] [CrossRef] [Green Version]
  49. Rafehi, H.; Orlowski, C.; Georgiadis, G.T.; Ververis, K.; El-Osta, A.; Karagiannis, T.C. Clonogenic assay: Adherent cells. J. Vis. Exp. 2011, e2573. [Google Scholar] [CrossRef]
  50. Ţigu, A.B.; Toma, V.A.; Mot, A.C.; Jurj, A.; Moldovan, C.S.; Fischer-Fodor, E.; Berindan-Neagoe, I.; Pârvu, M. The synergistic antitumor effect of 5-fluorouracil combined with allicin against lung and colorectal carcinoma cells. Molecules 2020, 25, 1947. [Google Scholar] [CrossRef]
Plants 11 00100 g001 550
Figure 1. Base peak chromatogram of L. alpinum callus cultures’ methanolic extract. Peak numbers correspond to the compounds from Table 1.
Figure 1. Base peak chromatogram of L. alpinum callus cultures’ methanolic extract. Peak numbers correspond to the compounds from Table 1.
Plants 11 00100 g001
Plants 11 00100 g002 550
Figure 2. Effects of L. alpinum extract on cell viability. The panel of cell lines includes breast, prostate, lung and colon cancer representatives, as well as human fibroblast BJ. Cells were exposed to the indicated concentrations of L. alpinum extract for 48 h. Untreated cells (blank control) were exposed only to culture media while positive controls were represented by cells treated with 100% DMSO. Cell viabilities are expressed as percentage of control (set as 100%) and represented as mean ± SEM (n = 3). Data was analyzed by one-way ANOVA followed by Dunnett’s multiple-comparison test. The asterisks *, **, *** and **** indicate significant difference at p < 0.05, p < 0.01, p < 0.001 and p < 0.0001, respectively, compared to corresponding control.
Figure 2. Effects of L. alpinum extract on cell viability. The panel of cell lines includes breast, prostate, lung and colon cancer representatives, as well as human fibroblast BJ. Cells were exposed to the indicated concentrations of L. alpinum extract for 48 h. Untreated cells (blank control) were exposed only to culture media while positive controls were represented by cells treated with 100% DMSO. Cell viabilities are expressed as percentage of control (set as 100%) and represented as mean ± SEM (n = 3). Data was analyzed by one-way ANOVA followed by Dunnett’s multiple-comparison test. The asterisks *, **, *** and **** indicate significant difference at p < 0.05, p < 0.01, p < 0.001 and p < 0.0001, respectively, compared to corresponding control.
Plants 11 00100 g002
Plants 11 00100 g003 550
Figure 3. Colony assay evaluation on ten cancer cell lines. (Statistical analysis: unpaired t-test was applied to determine significant differences in colony numbers. * p < 0.05, ** p < 0.01).
Figure 3. Colony assay evaluation on ten cancer cell lines. (Statistical analysis: unpaired t-test was applied to determine significant differences in colony numbers. * p < 0.05, ** p < 0.01).
Plants 11 00100 g003
Table
Table 1. Compound identifications obtained after LC-IM-MS analysis of L. alpinum callus cultures.
Table 1. Compound identifications obtained after LC-IM-MS analysis of L. alpinum callus cultures.
PeakRt
(Min)		m/z
Measured (Da)		m/z
Calculated (Da)		ΔmDaFormula [M − H]−Major FragmentsCCS (Å2)Tentative IdentificationIdentif.
Level *
10.87191.0561191.05560.6C7H11O6-113.55Quinic acid2
20.93191.0195191.01920.3C6H7O7111.0085113.23Glucaric acid—(H2O)2
31.15191.0195191.01920.3C6H7O7111.0086113.25Glucaric acid isomer—(H2O)2
42.18315.0722315.07160.6C13H15O9152.0109, 108.0214161.99Dihydroxybenzoic acid glucoside2
53.37353.0886353.08731.3C16H17O9191.0561171.81Chlorogenic acid **1
63.82533.0943533.09311.2C24H21O14371.0618, 191.0195206.43Di-caffeoyl-glucaric acid isomer2
74.17533.0943533.09311.2C24H21O14371.0617, 191.0195207.06Di-caffeoyl-glucaric acid isomer2
84.70533.0941533.09311.0C24H21O14371.0541, 191.0195209.91Di-caffeoyl-glucaric acid isomer2
94.74441.1396---431.1111, 395.1347, 233.0822196.85Unidentified-
105.13441.1396---431.1111, 395.1353, 233.0823194.03Unidentified-
115.54447.1333---267.0688, 187.1081, 132.0561190.84Unidentified-
125.74515.1194515.11900.4C25H23O12353.0869, 191.0540207.25Di-caffeoyl quinic acid isomer2
135.82695.1250695.12480.2C33H27O17533.094, 371.0616, 209.0295235.82Leontopodic acid B **1
145.89515.1192515.11900.2C25H23O12353.0884, 191.0559206.293-5-Dicaffeoylquinic
acid **		1
156.24695.1256695.12480.8C33H27O17533.0953, 371.0609, 209.0291237.11Leontopodic acid B
isomer		2
166.27515.1191515.11900.1C25H23O12353.0869210.01Di-caffeoylquinic acid
isomer		2
176.43781.1635781.16161.9C37H33O19619.1305, 457.0991, 295.0668, 191.0195, 161.0241252.37Leontopodic acid A **1
186.55781.1635781.16161.9C37H33O19619.1305, 457.0991, 295.0668, 191.0195, 161.0241254.65Leontopodic acid A
isomer		2
196.63687.2325---643.2434, 625.2344, 525.1796245.99Unidentified-
206.70285.0806---187.1138, 132.0585159.91Unidentified-
216.94689.2512---645.2613, 627.2507246.59Unidentified-
226.96689.2524---645.2619, 627.2514245.98Unidentified-
237.09311.0596---231.1030, 187.1129, 132.0581167.45Unidentified-
247.33857.1572857.15650.7C42H33O22695.1257, 533.0953, 371.0629, 209.0308, 191.0201261.88Tetra-caffeoyl glucaric acid2
257.41607.2763-- 563.2867, 463.2362, 301.1818, 209.0307242.57Unidentified-
267.55867.1991867.19840.7C41H39O21705.1687, 543.1373, 381.1049, 277.0576, 209.0280, 191.0202270.18Penta-substituted
derivative of glucaric acid		3
277.84283.0646---203.1081, 148.0531156.10Unidentified-
* Identification level confidence (as described by Schrimpe-Rutledge et al. [21]); ** Identified by comparison with reference standards.
Table
Table 2. Quantitative determination of the major constituents.
Table 2. Quantitative determination of the major constituents.
Compoundµg/mg of Dry
Extract		mg/g of Dry-Frozen
Callus Culture
Leontopodic acid A178.647.15
Leontopodic acid B219.958.05
Chlorogenic acid99.126.16
3-5-Dicaffeoylquinic acid73.719.45
Total571.3150.81
Table
Table 3. Summary of the in vitro effects of Leontopodium alpinum treatment on the investigated cell lines.
Table 3. Summary of the in vitro effects of Leontopodium alpinum treatment on the investigated cell lines.
Cancer Type ProstateColonLungBreast
Cell lineBJ22RV1LNCAPDLD-1HCT-116H1792SK-MES-1MDA-MB-231MDA-MB-468HS578TMCF-7
Viability assay+n.c.n.c.+++++++++++++++n.c.
MorphologyCell population reduction+++-++++++++++++-+-
Nuclear fragmentation-+++++++++-++++++
Cytoskeleton fragmentation-++++++-++++++++++
Rounding of cells-+++++++++++++++--+++
Multi-lobed nuclei-+--+-+--+-
Colony assayn.d.++++++++++
n.c.—no correlation; “+”—small effect; “++”—medium effect; “+++”—considerable effect; “-”—effect absent; n.d.—no data.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Pralea, I.-E.; Moldovan, R.-C.; Țigu, A.-B.; Petrache, A.-M.; Hegheș, S.-C.; Mitoi, M.; Cogălniceanu, G.; Iuga, C.-A. Profiling of Polyphenolic Compounds of Leontopodium alpinum Cass Callus Cultures Using UPLC/IM-HRMS and Screening of In Vitro Effects. Plants 2022, 11, 100. https://doi.org/10.3390/plants11010100

AMA Style

Pralea I-E, Moldovan R-C, Țigu A-B, Petrache A-M, Hegheș S-C, Mitoi M, Cogălniceanu G, Iuga C-A. Profiling of Polyphenolic Compounds of Leontopodium alpinum Cass Callus Cultures Using UPLC/IM-HRMS and Screening of In Vitro Effects. Plants. 2022; 11(1):100. https://doi.org/10.3390/plants11010100

Chicago/Turabian Style

Pralea, Ioana-Ecaterina, Radu-Cristian Moldovan, Adrian-Bogdan Țigu, Alina-Maria Petrache, Simona-Codruța Hegheș, Monica Mitoi, Gina Cogălniceanu, and Cristina-Adela Iuga. 2022. "Profiling of Polyphenolic Compounds of Leontopodium alpinum Cass Callus Cultures Using UPLC/IM-HRMS and Screening of In Vitro Effects" Plants 11, no. 1: 100. https://doi.org/10.3390/plants11010100

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop